Quantinuum

Last updated: June 4, 2026
Ticker
QNT
Exchange
NYSE
IPO Date
Pending
Price Range
$53.00 - $55.00
Deal Size
$1,431 million
View QNT Live Chart on TradingViewAffiliate link — we may earn a commission.

Company Snapshot

Quantinuum is a technology company focused on developing quantum computing solutions. The company operates through its subsidiaries and aims to leverage its expertise in quantum technology to provide innovative products and services. Their business model includes conducting operations through Quantinuum Holdings, where they maintain a significant economic interest.

Key Investors
Honeywell (49.1%)

Per S-1 disclosure; % may not sum to 100% when ownership is nested, multi-class, or reported on different bases.

Company Brief
Brief
Quantinuum is a Honeywell-backed quantum computing company formed in 2021 from the merger of Honeywell Quantum Solutions and Cambridge Quantum, now pursuing a roughly $1.0 billion U.S. IPO that implies a market capitalization of about $12.1 billion at the midpoint of the range. The deal would list Quantinuum on a U.S. exchange under the ticker QNT with an initial free float of about 8.3%.
Read Brief →
AI-generated research summary — not investment advice

Key Financials

Metric20252024
Revenue$30.9M$23.0M
YoY Growth+34.3%-
Adjusted Net Loss-$192.6M-$144.1M
Margin %-623.3%-626.5%

Balance Sheet

Cash & Equivalents
$762.6M

Implied Valuation at Midpoint

Market Cap
$13.7B
P/S Ratio
443.8x

Based on price range midpoint and most recent fiscal year data.

S-1 Highlights

Market & Competition

Quantinuum operates in the quantum computing industry, which is rapidly evolving and competitive. The company competes with established players such as IBM and Google.

Use of Proceeds

The proceeds from the IPO will be used by Quantinuum to purchase newly issued Common Units from Quantinuum Holdings and for general corporate purposes.

Key Risk Factors

  • Quantinuum's reliance on government contracts introduces uncertainty, as the U.S. Government Transaction is subject to negotiation and final approvals.
  • The company faces significant competition for talent, which could adversely affect their ability to innovate and grow.

Deal Structure

Primary Shares
21,052,632 shares
Shares Outstanding
253,937,247 shares
Post-IPO Float
10.4%
Lock-up
No Lock-up Agreement
Lead Underwriters
J.P. Morgan, Morgan Stanley, Jefferies, Evercore ISI

Reported Broker Availability

FidelityFidelity
E*TRADEE*TRADE

Reported by users or publicly disclosed. Information is for reference only.

Important: Information presented on this website is aggregated from publicly available sources and voluntary user submissions. It is provided for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. IPO access and availability may vary by broker and is not guaranteed; always verify details directly with your broker before making any investment decisions. We are not affiliated with, endorsed by, or acting on behalf of any broker-dealers, underwriters, or issuing companies. Some links to broker platforms may be affiliate links, and we may earn a commission if you open an account through those links. See full disclaimer for additional information.